Close

Interviews

Can an alternative drug delivery system finally help realise the potential of cancer vaccines?

1. Recent studies suggest great therapeutic potential of educating and unleashing our own immune system for cancer treatment; is this a holistic way forward? Many of those involved in cancer research are coming to the opinion that an appropriate mode...

BioAsia 2019: Exclusive Interview with Vivek Sharma, CEO, Piramal Pharma Solutions

Q1. The global Contract Development and Manufacturing Industry (CDMO) has witnessed steep growth over the past few years. What is your perspective on the evolution of the CDMO Industry and how is it shaping today‘s market? ...

In Conversation: FutureLink speaker Luca Pezzano discusses the Global Drug Safety, Supply and Traceability report

1. 88% of EU FMD CMOs are concerned that equipment shortages will affect their ability, or customer’s ability to comply with the regulations. Do you think this concern is warranted and why? Luca Pezzano: Vendor availability...

In Conversation : Jean-Marie Aulnette, Vice President of EMEA sales, TraceLink on Serialization And Traceability

What do you think is the biggest hurdle when it comes to serialization in the industry?The huge volume of data that will be generated and shared across the industry presents the greatest challenge. Serialization creates the need for a...

Anand Modi, VP Sales India at Tracelink, on Generic Companies In the Pharma Sector

How are Indian generics companies fairing in the competitive race to serialize and ship medicines to the US?Though the serialization deadline has passed for the Drug Supply Chain Security Act (DSCSA)in the US, companies across the globe are still...

Idifarma with its new automated capsule

1. What does this approval mean to Idifarma?It’s a great opportunity for growth, boosting our GMP capabilities with capsule filling in addition to immediate and modified release tablets. It is also a significant milestone in our journey so far,...

Innovative creative solutions to integrate development cycles

1. Will this merger change any of your organizational structure and framework?The partnership is not a merger, it is a collaboration between Recipharm and the Clinical Trial Consultants (CTC) to allow both companies to offer a complete service from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read